ストックスクリーナーアプリを入手
3.54
1.94%
-0.07
プレマーケット:
3.54
Rocket Pharmaceuticals Inc (RCKT) 最新ニュース
MSN Money - MSN
Analysts Offer Insights on Healthcare Companies: Omnicell (OMCL), Rocket Pharmaceuticals (RCKT) and Cullinan Management (CGEM) - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: Rocket Pharmaceuticals (RCKT) and TriSalus Life Sciences (TLSI) - The Globe and Mail
BofA Securities Maintains Rocket Pharmaceuticals(RCKT.US) With Buy Rating, Maintains Target Price $9 - Moomoo
US premarket movers: Argan, Rocket Pharmaceuticals, Unity - MSN
LifeSci Capital Maintains Rocket Pharmaceuticals(RCKT.US) With Buy Rating, Maintains Target Price $12 - Moomoo
Rocket Pharmaceuticals sells priority review voucher for $180M - Investing.com UK
Leerink raises Rocket Pharmaceuticals stock price target on PRV sale By Investing.com - Investing.com Canada
symbol__ Stock Quote Price and Forecast - CNN
Rocket Pharmaceuticals (RCKT) Enhances Financial Stability Throu - GuruFocus
Rocket Pharmaceuticals Monetizes Voucher to Extend Cash Runway - TipRanks
Rocket Pharmaceuticals to Sell Rare Pediatric Priority Review Voucher for $180 Million - TradingView
$180M PRV sale extends Rocket Pharmaceuticals (RCKT) cash runway to 2028 - Stock Titan
Rocket Pharmaceuticals sells priority review voucher for $180M By Investing.com - Investing.com South Africa
Rocket Pharmaceuticals Announces $180 Million Sale of Priority Review Voucher - The Joplin Globe
Rocket Pharmaceuticals sells priority review voucher for $180 million - StreetInsider
Lost Money on Rocket Pharmaceuticals, Inc. (RCKT)? Contact Levi & Korsinsky Before August 11, 2025 to Join Class Action - TMX Newsfile
Rocket Pharmaceuticals (RCKT) launches employee option exchange program - Stock Titan
Rocket Pharma wins FDA nod for gene therapy (update) - MSN
RCKTW Rocket quarterly earnings metrics not yet public as investors wait for management to share key operational updates.Real Trader Network - Xã Thanh Hà
RCKT (Rocket Pharmaceuticals Inc.) reports narrower Q4 2025 loss than analyst projections, shares tick up modestly after results.Earnings Analysis - Cổng thông tin điện tử tỉnh Tây Ninh
Lifesci Capital Has Pessimistic Outlook of RCKT Q1 Earnings - MarketBeat
Rocket Pharmaceuticals (RCKT) Stock Manual Trade (Grinds Lower) 2026-04-20Risk Reward Ratio - Cổng thông tin điện tử tỉnh Lào Cai
Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat
RCKT Technical Analysis | Trend, Signals & Chart Patterns | ROCKET PHARMACEUTICALS INC (NASDAQ:RCKT) - ChartMill
Rocket Pharmaceuticals, Inc. Warrant (RCKTW) - Minichart
Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Short Interest Update - MarketBeat
Rocket Pharma Advances Cardiac Gene Therapy Trial, Keeping RCKT on Investors’ Radar - TipRanks
Needham Maintains Rocket Pharmaceuticals(RCKT.US) With Hold Rating - Moomoo
Activity Recap: Is Rocket Pharmaceuticals Inc Equity Warrant a cyclical or defensive stock2026 News Drivers & Consistent Return Strategy Ideas - baoquankhu1.vn
Meme Stocks: Can Rocket Pharmaceuticals Inc expand into new markets2026 News Drivers & Stepwise Trade Execution Plans - baoquankhu1.vn
Big Picture: Will Rocket Pharmaceuticals Inc benefit from sector rotationQuarterly Portfolio Summary & High Accuracy Investment Entry Signals - baoquankhu1.vn
RCKT stock dives despite gene therapy approval — Wall Street dismisses sell-off - MSN
Volume Report: Can Rocket Pharmaceuticals Inc deliver consistent EPS growth2026 Stock Rankings & AI Forecast Swing Trade Picks - baoquankhu1.vn
Aug Ideas: Is Rocket Pharmaceuticals Inc exposed to political risk2026 Winners & Losers & AI Powered Buy and Sell Recommendations - baoquankhu1.vn
Rocket Pharmaceuticals (NASDAQ:RCKT) Shares Pass Below 50-Day Moving AverageHere's What Happened - MarketBeat
What is the growth rate of Rocket Pharmaceuticals (RCKT) Stock | Price at $3.56, Down 1.25%High Attention Stocks - Cổng thông tin điện tử tỉnh Lào Cai
What are the biggest risks for Rocket Pharmaceuticals (RCKT) Stock | Price at $3.48, Up 0.58%Investment Community Signals - Cổng thông tin điện tử Tỉnh Sơn La
[ARS] ROCKET PHARMACEUTICALS, INC. SEC Filing - Stock Titan
Rocket Pharmaceuticals (NASDAQ: RCKT) seeks vote on director slate and option exchange - Stock Titan
Rally Mode: Is Rocket Pharmaceuticals Inc stock a good dividend stockPrice Action & Technical Confirmation Alerts - baoquankhu1.vn
Rocket gene therapy, among FDA’s March approvals, earns PRV - biocentury.com
[SC TO-C] ROCKET PHARMACEUTICALS, INC. Tender Offer Communication | RCKT SEC FilingForm SC TO-C - Stock Titan
FDA Grants Accelerated Approval to Rocket Pharma’s Gene Therapy Kresladi for LAD-I - The Indian Practitioner
Rocket Pharmaceuticals, Inc. (RCKT) Stock Analysis: Exploring A Potential 138.80% Upside - DirectorsTalk Interviews
RCKTW SEC FilingsROCKET PHARMACEUTICALS INC 10-K, 10-Q, 8-K Forms - Stock Titan
Rocket Pharmaceuticals Inc (9IP1.DU) valuation measures and financial statistics - Yahoo Finance UK
First Therapy Funded by California Taxpayer Dollars is Approved to Treat Rare Childhood Disorder - Noticias Newswire
Momentum Shift: What are Rocket Pharmaceuticals Incs growth levers2026 Action & Fast Entry High Yield Tips - baoquankhu1.vn
0.14%
0.48%
大文字化:
|
ボリューム (24 時間):